SCHEMBL30948616

SCHEMBL30948616

CN1CCC(ONc2cccc([N+](=O)[O-])c2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.58
ALDH1A1 P00352 3/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
KMT2A Q03164 4/20 0.46
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
MEN1 O00255 3/20 0.43
DDX3X O00571 1/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
ACHE P22303 1/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1197657 0.80 PKM (0.68) PKMALDH1A1CYP2D6CYP2C9CYP2C19
SCHEMBL374672 0.77 SLC6A2 (0.60) PKMSMN1; SMN2CHRNB4CHRNA3LMNA
SCHEMBL3249583 0.74 TACR1 (0.52) PKMALDH1A1KMT2ACHRNB4CHRNA3
SCHEMBL18758028 0.74 MEN1 (0.49) ALDH1A1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL31509610 0.74 PKM (0.54) PKMALDH1A1KMT2ANPC1RAB9A
SCHEMBL25335598 0.74 SLC6A2 (0.59) PKMCHRNB4CHRNA3
SCHEMBL7057566 0.73 CHRNB4 (0.57) PKMCHRNB4CHRNA3LMNA
SCHEMBL25336072 0.73 SLC6A2 (0.57) PKMCHRNB4CHRNA3
SCHEMBL924103 0.73 SMN1; SMN2 (0.63) ALDH1A1KMT2ASMN1; SMN2MEN1DDX3X
SCHEMBL25336074 0.72 SLC6A2 (0.56) PKMALDH1A1CHRNB4CHRNA3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113677680-B EGFR inhibitor, composition and application thereof 贝达药业股份有限公司 2024-05-10 CN disclosed